Edition:
United Kingdom

People: Qiagen NV (QGEN.N)

QGEN.N on New York Stock Exchange

39.52USD
14 Jun 2019
Change (% chg)

$-0.10 (-0.25%)
Prev Close
$39.62
Open
$39.42
Day's High
$39.80
Day's Low
$39.40
Volume
358,362
Avg. Vol
362,081
52-wk High
$41.52
52-wk Low
$32.36

Schweins, Thomas 

Dr. Thomas Schweins has served as Senior Vice President Life Science Business Area, Member of the Executive Committee of Qiagen N.V. since 2017. He was Senior Vice President - Human Resources, Strategy & Marketing Services of the Company between 2012 and 2017. He leads QIAGEN’s initiatives to maximize human capital as well as the corporate strategy and marketing services teams. He joined QIAGEN in 2004 as Vice President Corporate Strategy and became Vice President Marketing & Strategy in 2005. In 2012 Dr. Schweins was named Senior Vice President Human Resources, Strategy & Marketing Services. He joined QIAGEN from The Boston Consulting Group, where he was a core team member of the Pharma/Health Care Area as well as the Corporate Development Practice Area. Before this, Dr. Schweins worked as Technology Manager and later as Assistant to the Management Board with Hoechst/Aventis. Dr. Schweins has a degree in Biochemistry from the University of Hanover. He obtained his Ph.D. at the Max-Planck-Gesellschaft / Max Planck Soceity and received a M.S. from the University of Southern California in Los Angeles, where he studied Business Administration and Chemistry.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --